- Home
- HASI vs TMDX Comparison
HASI vs TMDX Comparison
Compare HASI & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HASI
- TMDX
- Stock Information
- Founded
- HASI 1981
- TMDX 1998
- Country
- HASI United States
- TMDX United States
- Employees
- HASI N/A
- TMDX N/A
- Industry
- HASI Real Estate Investment Trusts
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HASI Real Estate
- TMDX Health Care
- Exchange
- HASI Nasdaq
- TMDX Nasdaq
- Market Cap
- HASI 3.6B
- TMDX 4.0B
- IPO Year
- HASI 2013
- TMDX 2019
- Fundamental
- Price
- HASI $27.71
- TMDX $131.54
- Analyst Decision
- HASI Strong Buy
- TMDX Buy
- Analyst Count
- HASI 6
- TMDX 11
- Target Price
- HASI $38.67
- TMDX $130.73
- AVG Volume (30 Days)
- HASI 1.2M
- TMDX 1.1M
- Earning Date
- HASI 11-06-2025
- TMDX 10-29-2025
- Dividend Yield
- HASI 6.06%
- TMDX N/A
- EPS Growth
- HASI N/A
- TMDX 170.70
- EPS
- HASI 1.59
- TMDX 2.54
- Revenue
- HASI $92,418,000.00
- TMDX $566,354,000.00
- Revenue This Year
- HASI $184.74
- TMDX $38.78
- Revenue Next Year
- HASI $13.79
- TMDX $20.76
- P/E Ratio
- HASI $17.45
- TMDX $51.87
- Revenue Growth
- HASI N/A
- TMDX 41.20
- 52 Week Low
- HASI $21.98
- TMDX $55.00
- 52 Week High
- HASI $36.56
- TMDX $145.50
- Technical
- Relative Strength Index (RSI)
- HASI 38.10
- TMDX 62.96
- Support Level
- HASI $27.72
- TMDX $120.80
- Resistance Level
- HASI $29.10
- TMDX $134.32
- Average True Range (ATR)
- HASI 0.80
- TMDX 7.31
- MACD
- HASI -0.24
- TMDX 1.72
- Stochastic Oscillator
- HASI 10.43
- TMDX 71.32
About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.